This bill directs the federal government to expand research, education, and data collection efforts focused on uterine fibroids, a condition affecting an estimated 26 million American women. The legislation authorizes $30 million annually from 2026 through 2030 for research conducted through the National Institutes of Health, addressing what Congress finds to be significantly underfunded research relative to the disease's impact. The bill also requires the Department of Health and Human Services to create a public education campaign about fibroid prevalence and treatment options, establish a database tracking Medicaid coverage of fibroid treatments, and work with healthcare providers to promote evidence-based care—with special attention to minority populations, who experience higher rates and more severe cases of uterine fibroids. Additional funding for education and healthcare provider outreach is authorized at levels to be determined for fiscal years 2026 through 2030. Overall, the bill aims to address gaps in research, awareness, and disparities in diagnosis and treatment for what Congress identifies as the leading cause of hysterectomies and a significant economic burden on the healthcare system.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.